Roth Capital Upgrades Trinity Biotech (TRIB) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Trinity Biotech plc (NASDAQ: TRIB) | Delayed: 6.43 -0.13 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.56 | 52 Week High | $13.68 | |||
| Open | $6.36 | 52 Week Low | $5.76 | |||
| Day High | $6.72 | P/E | N/A | |||
| Day Low | $6.33 | EPS | $0.00 | |||
| Volume | 4,272 | |||||
